not entirely unreasonable. This is why the Novartis agreement is now so significant, as without that or other significant partnership income then we’ll certainly be facing a CR in the first half of 2022. Unless there is a significant catalyst to drive the price up, it would be at these low levels which means significant dilution.
The market seemingly being at the top doesn’t help either as that’s just going to add further downward pressure. It’s so grim as a long right now. We just have to pray for some great news.
This weeks reporting dragging into tomorrow feels like further bad news (or no news) as well.
just a few more weeks hey…
MSB Trading 2021 - paradigm shift, page-8523
-
- There are more pages in this discussion • 1,688 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
93.0¢ |
Change
0.045(5.08%) |
Mkt cap ! $1.061B | |||
| Open | High | Low | Value | Volume |
| 88.5¢ | 95.0¢ | 88.0¢ | $3.322M | 3.613M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 13 | 71389 | 92.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 93.0¢ | 107399 | 5 |
View Market Depth
| Last trade - 12.55pm 06/08/2024 (20 minute delay) ? |
| MSB (ASX) Chart |